BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3397542)

  • 1. Immunochemical characterization of a glyco-inositol-phospholipid membrane antigen of Leishmania major.
    Elhay MJ; McConville MJ; Handman E
    J Immunol; 1988 Aug; 141(4):1326-31. PubMed ID: 3397542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid.
    Sacks DL; da Silva RP
    J Immunol; 1987 Nov; 139(9):3099-106. PubMed ID: 3312412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophosphoglycan and secreted acid phosphatase of Leishmania tropica share species-specific epitopes.
    Jaffe CL; Perez L; Schnur LF
    Mol Biochem Parasitol; 1990 Jun; 41(2):233-40. PubMed ID: 1697935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania tropica: characterization of a lipophosphoglycan-like antigen recognized by species-specific monoclonal antibodies.
    Jaffe CL; Pérez ML; Sarfstein R
    Exp Parasitol; 1990 Jan; 70(1):12-24. PubMed ID: 1688534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A family of glycoinositol phospholipids from Leishmania major. Isolation, characterization, and antigenicity.
    McConville MJ; Bacic A
    J Biol Chem; 1989 Jan; 264(2):757-66. PubMed ID: 2910865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Leishmania (Leishmania) tropica axenic amastigotes.
    Nasereddin A; Schweynoch C; Schonian G; Jaffe CL
    Acta Trop; 2010 Jan; 113(1):72-9. PubMed ID: 19782652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of Leishmania major-infected macrophages by use of lipophosphoglycan-specific monoclonal antibodies.
    Handman E
    Infect Immun; 1990 Jul; 58(7):2297-302. PubMed ID: 1694823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.
    Sacks DL; Hieny S; Sher A
    J Immunol; 1985 Jul; 135(1):564-9. PubMed ID: 2582050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glycoinositolphospholipid profiles of two Leishmania major strains that differ in lipophosphoglycan expression.
    McConville MJ; Bacic A
    Mol Biochem Parasitol; 1990 Jan; 38(1):57-67. PubMed ID: 2157154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and recovery of Leishmania antigen displayed on the surface membrane of mouse peritoneal macrophages infected in vitro.
    Williams KM; Sacci JB; Anthony RL
    J Immunol; 1986 Mar; 136(5):1853-8. PubMed ID: 3950404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antigenically distinct lipophosphoglycan on amastigotes of Leishmania major.
    Glaser TA; Moody SF; Handman E; Bacic A; Spithill TW
    Mol Biochem Parasitol; 1991 Apr; 45(2):337-44. PubMed ID: 1710036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PSA-2 glycoprotein complex of Leishmania major is a glycosylphosphatidylinositol-linked promastigote surface antigen.
    Murray PJ; Spithill TW; Handman E
    J Immunol; 1989 Dec; 143(12):4221-6. PubMed ID: 2592773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell reactivity to purified lipophosphoglycan from Leishmania major: a model for analysis of the cellular immune response to microbial carbohydrates.
    Moll H; Röllinghoff M
    Behring Inst Mitt; 1991 Feb; (88):161-9. PubMed ID: 2049034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania major: a very sensitive dot-blot ELISA for detection of parasites in cutaneous lesions.
    Handman E; Mitchell GF; Goding JW
    Mol Biol Med; 1987 Dec; 4(6):377-83. PubMed ID: 3437821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a phosphatidylinositol anchor in glycolipid antigens of Leishmania major.
    Sevlever D; Londner MV; Rosen G
    Biochem Int; 1989 Jul; 19(1):59-66. PubMed ID: 2550007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies specific for Leishmania tropica. I. Characterization of antigens associated with stage- and species-specific determinants.
    Jaffe CL; McMahon-Pratt D
    J Immunol; 1983 Oct; 131(4):1987-93. PubMed ID: 6194223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectivity of Leishmania braziliensis promastigotes is dependent on the increasing expression of a 65,000-dalton surface antigen.
    Kweider M; Lemesre JL; Darcy F; Kusnierz JP; Capron A; Santoro F
    J Immunol; 1987 Jan; 138(1):299-305. PubMed ID: 3782801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specific antibodies to Leishmania tropica (minor) recognize somatic antigens and exometabolites.
    Jaffe CL; Sarfstein R
    J Immunol; 1987 Aug; 139(4):1310-9. PubMed ID: 3302043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.